Co-Target(s) Information

Content Navigation (  All   None )                                      
Target General Information
Co-Targets of This Target
References
Target General Information  Top
Target ID T63505 Target Info
Target Name Tyrosine-protein kinase ABL1 (ABL)
Synonyms p150; Proto-oncogene tyrosine-protein kinase ABL1; Proto-oncogene c-Abl; JTK7; C-ABL; Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1
Target Type Successful Target
Gene Name ABL1
Biochemical Class Kinase
UniProt ID
ABL1_HUMAN
Co-Targets of This Target  Top
Co-Target Name Fms-like tyrosine kinase 3 (FLT-3) Successful Target
UniProt ID FLT3_HUMAN
Gene Name FLT3
Synonyms Stem cell tyrosine kinase 1; STK1; STK-1; Receptor-type tyrosine-protein kinase FLT3; Fetal liver kinase-2; FLT-3; FLK2; FLK-2; FL cytokine receptor; CD135
Representative Drug(s) Ponatinib Drug Info IC50 = 0.3 nM Click to Show More [1]
2 KW-2449 Drug Info IC50 = 6.6 nM [10]
Co-Target Name Proto-oncogene c-Ret (RET) Successful Target
UniProt ID RET_HUMAN
Gene Name RET
Synonyms RET51; RET receptor tyrosine kinase; RET mutant Y791F; RET mutant V804M; RET mutant V804L; RET mutant S891A; RET mutant M918T; RET mutant G691S; Proto-oncogene tyrosine-protein kinase receptor Ret; PTC; Cadherin family member 12; CDHR16; CDHF12; C-ret
Representative Drug(s) Ponatinib Drug Info IC50 = 0.3 nM [2]
Co-Target Name Fibroblast growth factor receptor 1 (FGFR1) Successful Target
UniProt ID FGFR1_HUMAN
Gene Name FGFR1
Synonyms c-fgr; bFGF-R-1; bFGF-R; N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT2; FLT-2; FLG; FGFR-1; FGFBR; CEK; CD331 antigen; CD331; Basic fibroblast growth factor receptor 1; BFGFR
Representative Drug(s) Ponatinib Drug Info IC50 = 0.7 nM [3]
Co-Target Name Proto-oncogene c-Src (SRC) Successful Target
UniProt ID SRC_HUMAN
Gene Name SRC
Synonyms pp60c-src; Tyrosine kinase (pp60(src)); Src tyrosine kinase; SRC1; Proto-oncogene tyrosine-protein kinase Src; Pp60(src); P60-Src; C-src TK; C-Src
Representative Drug(s) SKI-758 Drug Info IC50 = 0.78 nM Click to Show More [4]
2 Saracatinib Drug Info IC50 = 1 nM [5]
3 Bosutinib Drug Info IC50 = 1 nM [6]
4 Ponatinib Drug Info IC50 = 2.5 nM [2]
Co-Target Name Platelet-derived growth factor receptor beta (PDGFRB) Successful Target
UniProt ID PGFRB_HUMAN
Gene Name PDGFRB
Synonyms Platelet-derived growth factor receptor 1; PDGFR1; PDGFR-beta; PDGFR-1; PDGFR; PDGF-R-beta; CD140b antigen; CD140b; CD140 antigen-like family member B; Beta-type platelet-derived growth factor receptor; Beta-PDGFR; Beta platelet-derived growth factor receptor
Representative Drug(s) Ponatinib Drug Info IC50 = 1.2 nM [2]
Co-Target Name Fibroblast growth factor receptor 2 (FGFR2) Successful Target
UniProt ID FGFR2_HUMAN
Gene Name FGFR2
Synonyms Keratinocyte growth factor receptor 2; Keratinocyte growth factor receptor; KSAM; KGFR; K-sam; FGFR-2; FGF-2 receptor; CD332; BEK
Representative Drug(s) Ponatinib Drug Info IC50 = 1.3 nM [2]
Co-Target Name LCK tyrosine protein kinase (LCK) Successful Target
UniProt ID LCK_HUMAN
Gene Name LCK
Synonyms p56-LCK; Tyrosine-protein kinase Lck; T cell-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK; Proto-oncogene Lck; Protein YT16; Lymphocyte cell-specific protein-tyrosine kinase; Leukocyte C-terminal Src kinase; LSK; LCK p59-Fyn; LCK Protooncogene Syn
Representative Drug(s) Bosutinib Drug Info IC50 = 1.3 nM Click to Show More [6]
2 Saracatinib Drug Info IC50 < 4 nM [9]
3 SKI-758 Drug Info IC50 = 20 nM [4]
Co-Target Name Vascular endothelial growth factor receptor 2 (KDR) Successful Target
UniProt ID VGFR2_HUMAN
Gene Name KDR
Synonyms VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyrosine kinase receptor flk-1; Kinase insert domain receptor; Fetal liver kinase 1; FLK1; FLK-1; CD309
Representative Drug(s) Ponatinib Drug Info IC50 = 1.5 nM Click to Show More [7]
2 SKI-758 Drug Info IC50 ~ 1000 nM [4]
Co-Target Name Tyrosine-protein kinase Kit (KIT) Successful Target
UniProt ID KIT_HUMAN
Gene Name KIT
Synonyms v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; p145 c-kit; Proto-oncogene tyrosine-protein kinase Kit; Proto-oncogene c-Kit; Piebald trait protein; PBT; Mast/stem cell growth factor receptor Kit; CD117 antigen; CD117; C-kit
Representative Drug(s) Ponatinib Drug Info IC50 = 1.7 nM Click to Show More [8]
2 Bosutinib Drug Info IC50 = 32 nM [6]
3 Saracatinib Drug Info IC50 = 200 nM [9]
Co-Target Name Fyn tyrosine protein kinase (FYN) Successful Target
UniProt ID FYN_HUMAN
Gene Name FYN
Synonyms Tyrosine-protein kinase Fyn; Src-like kinase; SLK; Proto-oncogene tyrosine-protein kinase Fyn; Proto-oncogene c-Fyn; Proto-oncogene Syn; Fyn p59-Fyn; Fyn Protooncogene Syn
Representative Drug(s) Bosutinib Drug Info IC50 = 1.8 nM [6]
Co-Target Name Tyrosine-protein kinase BTK (ATK) Successful Target
UniProt ID BTK_HUMAN
Gene Name BTK
Synonyms Bruton's tyrosine kinase; Bruton tyrosine kinase; BPK; B-cell progenitor kinase; B cell progenitor kinase; Agammaglobulinemia tyrosine kinase; Agammaglobulinaemia tyrosine kinase; AGMX1
Representative Drug(s) Bosutinib Drug Info IC50 = 2.5 nM [6]
Co-Target Name Platelet-derived growth factor receptor alpha (PDGFRA) Successful Target
UniProt ID PGFRA_HUMAN
Gene Name PDGFRA
Synonyms RHEPDGFRA; Platelet-derived growth factor receptor 2; Platelet-derived growth factor alpha receptor; PDGFR2; PDGFR-alpha; PDGFR-2; PDGF-R-alpha; CD140a antigen; CD140a; CD140 antigen-like family member A; Alpha-type platelet-derived growth factor receptor; Alpha platelet-derived growth factor receptor
Representative Drug(s) Ponatinib Drug Info IC50 = 2.6 nM [2]
Co-Target Name Tropomyosin-related kinase A (TrkA) Successful Target
UniProt ID NTRK1_HUMAN
Gene Name NTRK1
Synonyms gp140trk; Tyrosine kinase receptor A; Tyrosine kinase receptor; Trk-A; TRKA; TRK1-transforming tyrosine kinase protein; TRK1 transforming tyrosinekinase protein; TRK; P140-TrkA; Neurotrophic tyrosine kinase receptor type 1; NGF-trk receptor type A; MTC; High affinity nerve growth factor receptor
Representative Drug(s) Bosutinib Drug Info IC50 = 22 nM [6]
Co-Target Name BDNF/NT-3 growth factors receptor (TrkB) Successful Target
UniProt ID NTRK2_HUMAN
Gene Name NTRK2
Synonyms Tropomyosin-related kinase B; TrkB tyrosine kinase; Trk-B; TRKB; Neurotrophic tyrosine kinase receptor type 2; GP145-TrkB
Representative Drug(s) Bosutinib Drug Info IC50 = 27 nM [6]
Co-Target Name Tyrosine-protein kinase SYK (SYK) Successful Target
UniProt ID KSYK_HUMAN
Gene Name SYK
Synonyms p72-Syk; Spleen tyrosine kinase
Representative Drug(s) Bosutinib Drug Info IC50 = 52 nM [6]
Co-Target Name Epidermal growth factor receptor (EGFR) Successful Target
UniProt ID EGFR_HUMAN
Gene Name EGFR
Synonyms Receptor tyrosine-protein kinase erbB-1; Proto-oncogene c-ErbB-1; HER1; ERBB1; ERBB
Representative Drug(s) Bosutinib Drug Info IC50 = 53 nM Click to Show More [6]
2 Saracatinib Drug Info IC50 = 66 nM [11]
3 SKI-758 Drug Info IC50 = 230 nM [4]
4 Ponatinib Drug Info IC50 ~ 1000 nM [2]
Co-Target Name Tyrosine-protein kinase UFO (AXL) Successful Target
UniProt ID UFO_HUMAN
Gene Name AXL
Synonyms UFO; Tyrosine-protein kinase receptor UFO; AXL oncogene
Representative Drug(s) Bosutinib Drug Info IC50 = 174 nM [6]
Co-Target Name Erbb2 tyrosine kinase receptor (HER2) Successful Target
UniProt ID ERBB2_HUMAN
Gene Name ERBB2
Synonyms p185erbB2; Tyrosine kinase-type cell surface receptor HER2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene c-ErbB-2; Proto-oncogene Neu; NGL; NEU; Metastatic lymph node gene 19 protein; MLN19; MLN 19; HER2; CD340
Representative Drug(s) Bosutinib Drug Info IC50 = 491 nM [6]
Co-Target Name Erbb4 tyrosine kinase receptor (Erbb-4) Successful Target
UniProt ID ERBB4_HUMAN
Gene Name ERBB4
Synonyms Tyrosine kinase-type cell surface receptor HER4; Receptor tyrosine-protein kinase erbB-4; Proto-oncogene-like protein c-ErbB-4; P180erbB4; HER4
Representative Drug(s) Bosutinib Drug Info IC50 = 491 nM [6]
Co-Target Name Cyclin-dependent kinase 4 (CDK4) Successful Target
UniProt ID CDK4_HUMAN
Gene Name CDK4
Synonyms PSK-J3; Cell division protein kinase 4
Representative Drug(s) SKI-758 Drug Info IC50 ~ 1000 nM [4]
Co-Target Name Tyrosine-protein kinase Lyn (JTK8) Clinical trial Target
UniProt ID LYN_HUMAN
Gene Name LYN
Synonyms p56Lyn; p53Lyn; V-yes-1 Yamaguchi sarcoma viral related oncogene homolog; Lck/Yes-related novel protein tyrosine kinase
Representative Drug(s) Ponatinib Drug Info IC50 = 0.24 nM Click to Show More [7]
2 Bosutinib Drug Info IC50 = 8 nM [6]
Co-Target Name Yes tyrosine kinase (YES) Clinical trial Target
UniProt ID YES_HUMAN
Gene Name YES1
Synonyms p61-Yes; Yes p59-Fyn; Yes Protooncogene Syn; Tyrosine-protein kinase Yes; Proto-oncogene c-Yes
Representative Drug(s) Bosutinib Drug Info IC50 = 0.4 nM Click to Show More [6]
2 Saracatinib Drug Info IC50 = 0.7 nM [12]
3 DCC-2036 Drug Info IC50 = 1.5 nM [12]
Co-Target Name ERK activator kinase 1 (MEK1) Clinical trial Target
UniProt ID MP2K1_HUMAN
Gene Name MAP2K1
Synonyms PRKMK1; Mitogen-activated protein kinase kinase 1; MKK1; MEK 1; MAPKK 1; MAPK/ERKkinase 1; MAPK/ERK kinase 1; MAP kinase kinase 1; Dual specificity mitogen-activated protein kinase kinase 1
Representative Drug(s) Bosutinib Drug Info IC50 = 1 nM [13]
Co-Target Name Ephrin type-B receptor 4 (EPHB4) Clinical trial Target
UniProt ID EPHB4_HUMAN
Gene Name EPHB4
Synonyms Tyrosine-protein kinase TYRO11; TYRO11; MYK1; Hepatoma transmembrane kinase; HTK
Representative Drug(s) Bosutinib Drug Info IC50 = 5.5 nM [6]
Co-Target Name Fibroblast growth factor receptor 4 (FGFR4) Clinical trial Target
UniProt ID FGFR4_HUMAN
Gene Name FGFR4
Synonyms TKF; JTK2; FGFR-4; CD334
Representative Drug(s) Ponatinib Drug Info IC50 = 7.1 nM [2]
Co-Target Name Ephrin type-B receptor 2 (EPHB2) Clinical trial Target
UniProt ID EPHB2_HUMAN
Gene Name EPHB2
Synonyms hEK5; Tyrosine-protein kinase receptor EPH-3; Tyrosine-protein kinase TYRO5; TYRO5; Renal carcinoma antigen NY-REN-47; Receptor protein-tyrosine kinase HEK5; EphB2 receptor tyrosine kinase; EphB2; EPTH3; EPHT3; EPH-like kinase 5; EPH tyrosine kinase 3; ELK-related tyrosine kinase; EK5; Developmentally-regulated Eph-related tyrosine kinase; DRT
Representative Drug(s) Bosutinib Drug Info IC50 = 8.5 nM [6]
Co-Target Name Fibroblast growth factor receptor 3 (FGFR3) Clinical trial Target
UniProt ID FGFR3_HUMAN
Gene Name FGFR3
Synonyms JTK4; FGFR-3; CD333
Representative Drug(s) Ponatinib Drug Info IC50 = 9.4 nM [2]
Co-Target Name Receptor-interacting protein 1 (RIPK1) Clinical trial Target
UniProt ID RIPK1_HUMAN
Gene Name RIPK1
Synonyms Receptor-interacting serine/threonine-protein kinase 1; RIP1; RIP-1; RIP; Cell death protein RIP
Representative Drug(s) Ponatinib Drug Info IC50 = 12 nM [14]
Co-Target Name Vascular endothelial growth factor receptor 1 (FLT-1) Clinical trial Target
UniProt ID VGFR1_HUMAN
Gene Name FLT1
Synonyms Vascular permeability factor receptor; VEGFR1; VEGFR-1; VEGF-1 receptor; Tyrosine-protein kinase receptor FLT; Tyrosine-protein kinase FRT; Fms-like tyrosine kinase 1; FRT; FLT
Representative Drug(s) Ponatinib Drug Info IC50 = 20.9 nM [2]
Co-Target Name P2Y purinoceptor 2 (P2RY2) Clinical trial Target
UniProt ID P2RY2_HUMAN
Gene Name P2RY2
Synonyms P2Y2; P2U1; P2U receptor; P2U purinoceptor 1; P2U nucleotide receptor; P2RY2; Adenosine P2Y2 receptor
Representative Drug(s) Adenosine triphosphate Drug Info EC50 = 30.1 nM [15]
Co-Target Name P2X purinoceptor 3 (P2RX3) Clinical trial Target
UniProt ID P2RX3_HUMAN
Gene Name P2RX3
Synonyms P2X3 receptor; P2X3; P2RX3; ATP-gated ion channel P2X(3)
Representative Drug(s) Adenosine triphosphate Drug Info EC50 = 340 nM [16]
Co-Target Name Erbb3 tyrosine kinase receptor (Erbb-3) Clinical trial Target
UniProt ID ERBB3_HUMAN
Gene Name ERBB3
Synonyms Tyrosine kinase-type cell surface receptor HER3; Receptor tyrosine-protein kinase erbB-3; Proto-oncogene-like protein c-ErbB-3; HER3; C-erbB3; C-erbB-3 protein
Representative Drug(s) Bosutinib Drug Info IC50 = 491 nM [6]
Co-Target Name P2X purinoceptor 4 (P2RX4) Clinical trial Target
UniProt ID P2RX4_HUMAN
Gene Name P2RX4
Synonyms P2X4; P2RX4
Representative Drug(s) Adenosine triphosphate Drug Info EC50 = 500 nM [16]
Co-Target Name Focal adhesion kinase 1 (FAK) Clinical trial Target
UniProt ID FAK1_HUMAN
Gene Name PTK2
Synonyms pp125FAK; p125FAK; Protein-tyrosine kinase 2; Protein phosphatase 1 regulatory subunit 71; PPP1R71; Focal adhesion kinase-related nonkinase; FRNK; FAK1; FADK 1; FADK
Representative Drug(s) Bosutinib Drug Info IC50 = 538 nM [6]
Co-Target Name Renal carcinoma antigen NY-REN-64 (IRAK-4) Clinical trial Target
UniProt ID IRAK4_HUMAN
Gene Name IRAK4
Synonyms Interleukin-1 receptor-associated kinase 4; IRAK-4
Representative Drug(s) Bosutinib Drug Info IC50 = 574 nM [6]
Co-Target Name RAC-alpha serine/threonine-protein kinase (AKT1) Clinical trial Target
UniProt ID AKT1_HUMAN
Gene Name AKT1
Synonyms RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; PKB alpha
Representative Drug(s) SKI-758 Drug Info IC50 ~ 1000 nM [4]
Co-Target Name Phosphoinositide dependent protein kinase-1 (PDPK1) Clinical trial Target
UniProt ID PDPK1_HUMAN
Gene Name PDPK1
Synonyms PDK1; HPDK1; 3-phosphoinositide-dependent protein kinase 1; 3-Phosphoinositide-dependent kinase-1; 3'-phosphoinositide dependent kinase 1
Representative Drug(s) SKI-758 Drug Info IC50 ~ 1000 nM [4]
Co-Target Name Tyrosine-protein kinase BMX (BMX) Patented-recorded Target
UniProt ID BMX_HUMAN
Gene Name BMX
Synonyms NTK38; Epithelial and endothelial tyrosine kinase; ETK; Cytoplasmic tyrosine-protein kinase BMX; Bone marrow tyrosine kinase gene in chromosome X protein
Representative Drug(s) Bosutinib Drug Info IC50 = 1 nM [13]
Co-Target Name Activated CDC42 kinase 1 (ACK-1) Patented-recorded Target
UniProt ID ACK1_HUMAN
Gene Name TNK2
Synonyms Tyrosine kinase non-receptor protein 2; ACK1; ACK-1
Representative Drug(s) Bosutinib Drug Info IC50 = 2.7 nM [6]
Co-Target Name Hematopoietic cell kinase (HCK) Patented-recorded Target
UniProt ID HCK_HUMAN
Gene Name HCK
Synonyms p61Hck; p59Hck; p59-HCK/p60-HCK; Tyrosine-protein kinase HCK; Hemopoietic cell kinase
Representative Drug(s) Bosutinib Drug Info IC50 = 3.2 nM [6]
Co-Target Name MEK kinase kinase 2 (MAP4K2) Patented-recorded Target
UniProt ID M4K2_HUMAN
Gene Name MAP4K2
Synonyms Rab8-interacting protein; RAB8IP; Mitogen-activated protein kinase kinase kinase kinase 2; MEKKK 2; MAPK/ERK kinase kinase kinase 2; Germinal center kinase; GCK; GC kinase; B lymphocyte serine/threonine-protein kinase
Representative Drug(s) Bosutinib Drug Info IC50 = 9.9 nM [6]
Co-Target Name Tyrosine-protein kinase CSK (CSK) Patented-recorded Target
UniProt ID CSK_HUMAN
Gene Name CSK
Synonyms Protein-tyrosine kinase CYL; C-Src kinase
Representative Drug(s) Bosutinib Drug Info IC50 = 63 nM Click to Show More [6]
2 Saracatinib Drug Info IC50 = 840 nM [9]
Co-Target Name Tyrosine-protein kinase Tec (PSCTK4) Patented-recorded Target
UniProt ID TEC_HUMAN
Gene Name TEC
Synonyms Tec protein tyrosine kinase
Representative Drug(s) Bosutinib Drug Info IC50 = 282 nM [6]
Co-Target Name NF-kappa-B-activating kinase (TBK1) Patented-recorded Target
UniProt ID TBK1_HUMAN
Gene Name TBK1
Synonyms TANK-binding kinase 1; T2K; Serine/threonine-protein kinase TBK1; NAK
Representative Drug(s) Bosutinib Drug Info IC50 = 471 nM [6]
Co-Target Name Tyrosine-protein kinase ABL2 (ABL2) Literature-reported Target
UniProt ID ABL2_HUMAN
Gene Name ABL2
Synonyms Tyrosine-protein kinase ARG; Abelson-related gene protein; Abelson tyrosine-protein kinase 2; Abelson murine leukemia viral oncogene homolog 2; ARG; ABLL
Representative Drug(s) Bosutinib Drug Info IC50 = 0.5 nM [6]
Co-Target Name Tyrosine-protein kinase Fgr (FGR) Literature-reported Target
UniProt ID FGR_HUMAN
Gene Name FGR
Synonyms p58c-Fgr; p58-Fgr; p55-Fgr; SRC2; Proto-oncogene c-Fgr; Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog
Representative Drug(s) Bosutinib Drug Info IC50 = 1.1 nM [6]
Co-Target Name Membrane-associated kinase (PKMYT1) Literature-reported Target
UniProt ID PMYT1_HUMAN
Gene Name PKMYT1
Synonyms Myt1 kinase; Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase; MYT1
Representative Drug(s) Bosutinib Drug Info Ki = 12.7 nM Click to Show More [17]
2 Saracatinib Drug Info Ki = 39.8 nM [17]
Co-Target Name Tyrosine-protein kinase TXK (TXK) Literature-reported Target
UniProt ID TXK_HUMAN
Gene Name TXK
Synonyms Resting lymphocyte kinase; RLK; Protein-tyrosine kinase 4; PTK4
Representative Drug(s) Bosutinib Drug Info IC50 = 40 nM [6]
Co-Target Name P2X purinoceptor 1 (P2RX1) Literature-reported Target
UniProt ID P2RX1_HUMAN
Gene Name P2RX1
Synonyms Purinergic receptor 1; P2X1
Representative Drug(s) Adenosine triphosphate Drug Info EC50 = 56 nM [16]
Co-Target Name Focal adhesion kinase 2 (PTK2B) Literature-reported Target
UniProt ID FAK2_HUMAN
Gene Name PTK2B
Synonyms Related adhesion focal tyrosine kinase; RAFTK; Protein-tyrosine kinase 2-beta; Proline-rich tyrosine kinase 2; PYK2; FAK2; FADK 2; Cell adhesion kinase beta; Calcium-regulated non-receptor proline-rich tyrosine kinase; Calcium-dependent tyrosine kinase; CAKB; CAK-beta; CADTK
Representative Drug(s) Bosutinib Drug Info IC50 = 134 nM [6]
Co-Target Name P2Y purinoceptor 1 (P2RY1) Literature-reported Target
UniProt ID P2RY1_HUMAN
Gene Name P2RY1
Synonyms P2Y1; P2Y(1) receptor; P2RY1; Adenosine P2Y1 receptor
Representative Drug(s) Adenosine triphosphate Drug Info EC50 = 150 nM [18]
Co-Target Name MST-1 protein kinase (STK4) Literature-reported Target
UniProt ID STK4_HUMAN
Gene Name STK4
Synonyms Serine/threonine-protein kinase Krs-2; Serine/threonine-protein kinase 4 18kDa subunit; Serine/threonine-protein kinase 4; STE20-like kinase MST1; Mammalian STE20-like protein kinase 1; MST1/N; MST1/C; MST1; MST-1; KRS2
Representative Drug(s) Bosutinib Drug Info IC50 = 191 nM [6]
Co-Target Name Proto-oncogene c-Fes (FES) Literature-reported Target
UniProt ID FES_HUMAN
Gene Name FES
Synonyms p93c-fes; Tyrosine-protein kinase Fes/Fps; Proto-oncogene c-Fps; Feline sarcoma/Fujinami avian sarcoma oncogene homolog; FPS
Representative Drug(s) Bosutinib Drug Info IC50 = 358 nM [6]
Co-Target Name Proto-oncogene c-Fer (FER) Literature-reported Target
UniProt ID FER_HUMAN
Gene Name FER
Synonyms p94-Fer; Tyrosine-protein kinase Fer; Tyrosine kinase 3; TYK3; Fujinami poultry sarcoma/Feline sarcoma-related protein Fer; Feline encephalitis virus-related kinase FER
Representative Drug(s) Bosutinib Drug Info IC50 = 490 nM [6]
Co-Target Name Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5) Co-Target
UniProt ID M4K5_HUMAN
Gene Name MAP4K5
Synonyms Kinase homologous to SPS1/STE20; KHS; MAPK/ERK kinase kinase kinase 5; MEK kinase kinase 5; MEKKK 5
Representative Drug(s) Bosutinib Drug Info IC50 = 0.3 nM [6]
Co-Target Name Serine/threonine-protein kinase RIPK2 (RIPK2) Co-Target
UniProt ID RIPK2_HUMAN
Gene Name RIPK2
Synonyms Receptor-interacting serine/threonine-protein kinase 2; CARD-containing interleukin-1 beta-converting enzyme-associated kinase; CARD-containing IL-1 beta ICE-kinase; RIP-like-interacting CLARP kinase; Receptor-interacting protein 2; RIP-2; Tyrosine-protein kinase RIPK2
Representative Drug(s) Ponatinib Drug Info IC50 = 1 nM [14]
Co-Target Name Receptor-interacting serine/threonine-protein kinase 3 (RIPK3) Co-Target
UniProt ID RIPK3_HUMAN
Gene Name RIPK3
Synonyms RIP-like protein kinase 3; Receptor-interacting protein 3; RIP-3
Representative Drug(s) Ponatinib Drug Info IC50 = 1.6 nM [14]
Co-Target Name Tyrosine-protein kinase FRK (FRK) Co-Target
UniProt ID FRK_HUMAN
Gene Name FRK
Synonyms FYN-related kinase; Nuclear tyrosine protein kinase RAK; Protein-tyrosine kinase 5
Representative Drug(s) Bosutinib Drug Info IC50 = 2.2 nM [6]
Co-Target Name Serine/threonine-protein kinase 24 (STK24) Co-Target
UniProt ID STK24_HUMAN
Gene Name STK24
Synonyms Mammalian STE20-like protein kinase 3; MST-3; STE20-like kinase MST3
Representative Drug(s) Bosutinib Drug Info IC50 = 3.9 nM [6]
Co-Target Name Misshapen-like kinase 1 (MINK1) Co-Target
UniProt ID MINK1_HUMAN
Gene Name MINK1
Synonyms GCK family kinase MiNK; MAPK/ERK kinase kinase kinase 6; MEK kinase kinase 6; MEKKK 6; Misshapen/NIK-related kinase; Mitogen-activated protein kinase kinase kinase kinase 6
Representative Drug(s) Bosutinib Drug Info IC50 = 22 nM [6]
Co-Target Name Serine/threonine-protein kinase 10 (STK10) Co-Target
UniProt ID STK10_HUMAN
Gene Name STK10
Synonyms Lymphocyte-oriented kinase
Representative Drug(s) Bosutinib Drug Info IC50 = 52 nM [6]
Co-Target Name CaM kinase I delta (CAMK1D) Co-Target
UniProt ID KCC1D_HUMAN
Gene Name CAMK1D
Synonyms Calcium/calmodulin-dependent protein kinase type 1D; CaM kinase ID; CaM-KI delta; CaMKI delta; CaMKID; CaMKI-like protein kinase; CKLiK
Representative Drug(s) Bosutinib Drug Info IC50 = 92 nM [6]
Co-Target Name Nucleophosmin-ALK tyrosine kinase receptor fusion protein (NPM-ALK) Co-Target
UniProt ID NPM_HUMAN-ALK_HUMAN
Gene Name NPM1-ALK
Representative Drug(s) Bosutinib Drug Info IC50 = 150 nM [19]
Co-Target Name Coiled coil domain containing protein 6-Proto oncogene c Ret complex (CCDC6-RET) Co-Target
UniProt ID CCDC6_HUMAN-RET_HUMAN
Gene Name CCDC6-RET
Representative Drug(s) Ponatinib Drug Info IC50 = 180.4 nM [20]
Co-Target Name CaM kinase II gamma (CAMK2G) Co-Target
UniProt ID KCC2G_HUMAN
Gene Name CAMK2G
Synonyms Calcium/calmodulin-dependent protein kinase type II subunit gamma; CaM kinase II subunit gamma; CaMK-II subunit gamma
Representative Drug(s) Bosutinib Drug Info IC50 = 184 nM [6]
References  Top
REF 1 Inhibitors of Stat5 protein signalling. Medchemcomm. 2012;3:22-7.
REF 2 Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors. Eur J Med Chem. 2017 Jan 27;126:122-32.
REF 3 Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3beta (GSK-3beta) with cellular activity of promoting glucose uptake. Bioorg Med Chem Lett. 2014 Dec 15;24(24):5639-43.
REF 4 Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles. J Med Chem. 2006 Dec 28;49(26):7868-76.
REF 5 c-Src protein kinase inhibitors block assembly and maturation of dengue virus. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3520-5.
REF 6 Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia. 2009 Mar;23(3):477-85.
REF 7 An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors. Eur J Med Chem. 2017 Jan 27;126:476-90.
REF 8 Inhibitors to Overcome Secondary Mutations in the Stem Cell Factor Receptor KIT. J Med Chem. 2017 Nov 9;60(21):8801-15.
REF 9 Emerging targets in osteoporosis disease modification. J Med Chem. 2010 Jun 10;53(11):4332-53.
REF 10 Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases. Eur J Med Chem. 2019 Dec 15;184:111710.
REF 11 Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma. J Med Chem. 2019 May 9;62(9):4772-4778.
REF 12 Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorg Med Chem Lett. 2013 Aug 1;23(15):4398-403.
REF 13 AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective. J Med Chem. 2016 Apr 28;59(8):3593-608.
REF 14 Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives. J Med Chem. 2020 Feb 27;63(4):1490-1510.
REF 15 Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling. J Med Chem. 2009 May 14;52(9):2762-75.
REF 16 Purine and pyrimidine (P2) receptors as drug targets. J Med Chem. 2002 Sep 12;45(19):4057-93.
REF 17 Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and II. Bioorg Med Chem. 2018 Aug 7;26(14):4014-4024.
REF 18 Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors. J Med Chem. 2010 Dec 23;53(24):8485-97.
REF 19 Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and hom... J Med Chem. 2006 Sep 21;49(19):5759-68.
REF 20 Discovery of 4-chloro-3-(5-(pyridin-3-yl)-1,2,4-oxadiazole-3-yl)benzamides as novel RET kinase inhibitors. Bioorg Med Chem Lett. 2016 Dec 1;26(23):5679-5684.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.